Results 161 to 170 of about 84,076 (240)

Interpretable learning of temporal cellular dynamics from single-cell data. [PDF]

Cell Rep Methods
Kouadri Boudjelthia I, Milite S, El Kazwini N, Huang Y, Sottoriva A, Sanguinetti G.   +5 more
europepmc   +1 more source

Cancro cítrico

Plant Health Instructor, 2013
openaire   +1 more source

Bone marrow immune cell composition reflects multiple myeloma progression and affects treatment response. [PDF]

Blood Neoplasia
Corsale AM, Azgomi MS, Gigliotta E, Di Simone M, Pacelli P, Cioffi F, Bestoso E, Raspadori D, Gozzetti A, Solimando A, Tabares P, Beilhack A, Speciale M, Corsale G, Sciortino M, Aquilina C, Brucato F, Cea M, Zambello R, Garofano F, Biondo M, Buffa F, Caccamo N, Dieli F, Meraviglia S, Siragusa S, Botta C.   +26 more
europepmc   +1 more source

The consequences of absconding from mental hospitals [PDF]

, 1998
Andoh, Benjamin
core   +1 more source

Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody. [PDF]

Cancer Immunol Immunother
Zaninelli S, Cattaneo I, Valgardsdottir R, Frapolli R, Bello E, Meroni M, Gianatti A, Panna S, Rizzo P, Tomasoni S, D'Incalci M, Introna M, Golay J, Rambaldi A.   +13 more
europepmc   +1 more source

Second-line chemotherapy after gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: comparative outcomes and AI-guided treatment selection. [PDF]

Oncologist
Procaccio L, Giordano G, Nichetti F, Milella M, Pretta A, Iacono D, Niger M, Casalino S, Vivaldi C, De Vita F, Pusceddu V, Landriscina M, Di Paolo G, Sperotto S, Masucci M, Tortora G, Bianco R, Vasile E, Zaniboni A, Miceli CC, Ongaro E, Giommoni E, Tinè G, Barsotti G, Marchesi S, Di Marco M, Ortolani S, Aprile G, Scartozzi M, Bergamo F, Melisi D, Lonardi S.   +31 more
europepmc   +1 more source

v. 44, no. 1, January 27, 1978 [PDF]

, 1978

core   +1 more source

A machine learning model including pentraxin-3 as predictor of outcomes in community-acquired pneumonia. [PDF]

J Transl Med
Voza A, Aliberti S, Bonelli F, Ingallinella P, Ghezzi E, Mauro C, Rossini C, Mastronardo C, Felotti S, Bottazzi B, Garlanda C, Zierold C, Ghignoni G, Mantovani A.   +13 more
europepmc   +1 more source

Catecolaminas, stresse e cancro [PDF]

, 2012
Miguel Eduardo Teixeira Moz Gonçalves
core  

Programmed death-ligand 1 expression and prognostic significance in bevacizumab treated ovarian cancer patients: Results from the phase IV MITO16A/MaNGO OV-2 translational study. [PDF]

Clin Transl Med
Basso-Valentina F, Canzonieri V, De Cecio R, Arenare L, Lorusso D, Cecere SC, Pivetta E, Russo D, Di Mauro A, Artioli G, Spina A, De Angelis C, Califano D, Cinieri S, Scognamiglio G, Salutari V, Chiodini P, Perrone F, Pignata S, Baldassarre G.   +19 more
europepmc   +1 more source